China National Accord Medicines Corporation Ltd. (SHE:000028)
China · Delayed Price · Currency is CNY 20.58
+0.05 (0.24%)
Oct 22, 2026, 3:05 PM CST
SHE:000028 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 72,886 | 73,416 | 74,378 | 75,477 | 73,443 | 68,358 |
Revenue Growth | -0.69% | -1.29% | -1.46% | 2.77% | 7.44% | 14.60% |
Gross Profit Gross Profit Growth | 7,505 | 7,797 | 8,198 | 9,006 | 8,883 | 7,986 |
Operating Income Operating Income Growth | 1,653 | 1,720 | 1,556 | 2,411 | 2,298 | 2,031 |
Net Income Net Income Growth | 1,076 | 1,136 | 642.49 | 1,599 | 1,487 | 1,336 |
Earnings Per Share EPS Growth | 1.75 | 1.85 | 1.05 | 2.61 | 2.43 | 2.18 |
EPS Growth | 91.01% | 77.38% | -59.93% | 7.49% | 11.25% | -4.59% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Headquarters Headquarters Growth | 7.71 |
Distribution Distribution Growth | 53,321 |
Retail Retail Growth | 20,981 |
Offset of Business Segment Offset of Business Segment Growth | -893.99 |
Total Total Growth | 73,416 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,933 | 7,802 | 7,409 | 6,502 | 6,016 | 5,126 |
Total Debt Total Debt Growth | 3,572 | 4,507 | 5,737 | 5,374 | 4,391 | 4,786 |
Net Cash (Debt) Net Cash Growth | 2,361 | 3,295 | 1,671 | 1,129 | 1,626 | 340.48 |
Net Cash Growth | 8009.05% | 97.18% | 48.07% | -30.58% | 377.51% | -82.99% |
Net Cash Per Share Net Cash Per Share Growth | 3.85 | 5.38 | 2.72 | 1.84 | 2.66 | 0.56 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 104.8 | 1,639 | 3,271 | 2,937 | 2,560 | 1,655 |
Capital Expenditures CapEx Growth | -162.36 | -217.35 | -282.7 | -322.21 | -322.19 | -370.43 |
Free Cash Flow Free Cash Flow Growth | -57.56 | 1,421 | 2,989 | 2,615 | 2,238 | 1,285 |
Free Cash Flow Growth | - | -52.45% | 14.30% | 16.83% | 74.22% | 6.27% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 10.30% | 10.62% | 11.02% | 11.93% | 12.09% | 11.68% |
Operating Margin | 2.27% | 2.34% | 2.09% | 3.19% | 3.13% | 2.97% |
Pretax Margin | 1.95% | 2.06% | 0.77% | 3.28% | 3.15% | 2.89% |
Profit Margin | 1.48% | 1.55% | 0.86% | 2.12% | 2.02% | 1.96% |
FCF Margin | -0.08% | 1.94% | 4.02% | 3.46% | 3.05% | 1.88% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.560 | 0.560 | 0.333 | 0.618 | 0.559 | 0.420 |
Dividend Per Share Growth | 85.14% | 68.32% | -46.18% | 10.49% | 33.34% | -24.99% |
Dividend Yield | 2.72% | 2.68% | 1.34% | 2.53% | 2.60% | 1.75% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.73 | 11.24 | 23.59 | 9.34 | 8.85 | 11.00 |
Forward PE | 10.92 | 10.36 | 16.43 | 10.10 | 10.14 | 10.13 |
P/FCF Ratio | - | 8.99 | 5.07 | 5.71 | 5.88 | 11.45 |
PS Ratio | 0.16 | 0.17 | 0.20 | 0.20 | 0.18 | 0.22 |